Rezultati - Nalini Jayaprakash
- Showing 1 - 11 results of 11
-
1
-
2
-
3
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias od Nirali N. Shah, Melinda S. Merchant, Diane E. Cole, Nalini Jayaprakash, Donna Bernstein, Cindy Delbrook, Kelly Richards, Brigitte C. Widemann, Alan S. Wayne
Izdano 2016Artigo -
4
Efficacy of Glucarpidase (Carboxypeptidase <scp>G</scp>2) in Patients with Acute Kidney Injury After High‐Dose Methotrexate Therapy od Brigitte C. Widemann, Stefan Schwartz, Nalini Jayaprakash, Robbin Christensen, Ching‐Hon Pui, Nikhil Chauhan, Claire Daugherty, Thomas King, Janet E. Rush, Scott C. Howard
Izdano 2013Artigo -
5
Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibr... od Brigitte C. Widemann, Wanda L. Salzer, R.J. Arceci, Susan M. Blaney, Elizabeth Fox, David W. End, Andrea Gillespie, Patricia Whitcomb, Joseph S. Palumbo, Aaron Pitney, Nalini Jayaprakash, Peter Zannikos, Frank M. Balis
Izdano 2006Artigo -
6
Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome od Brigitte C. Widemann, Frank M. Balis, AeRang Kim, Matthew Boron, Nalini Jayaprakash, Aiman Shalabi, M O'Brien, Michelle Eby, Diane E. Cole, Robert F. Murphy, Elizabeth Fox, Percy Ivy, Peter C. Adamson
Izdano 2010Artigo -
7
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas od AeRang Kim, Eva Dombi, Kathleen Tepas, Elizabeth Fox, Staci Martin, Pamela L. Wolters, Frank M. Balis, Nalini Jayaprakash, Barış Türkbey, Naira Muradyan, Peter L. Choyke, Alyssa Reddy, Bruce R. Korf, Brigitte C. Widemann
Izdano 2012Artigo -
8
A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractor... od Elizabeth Fox, Richard Aplenc, Rochelle Bagatell, Meredith K. Chuk, Eva Dombi, Wendy Goodspeed, Anne Goodwin, Marie Kromplewski, Nalini Jayaprakash, Marcelo Marotti, Kathryn H. Brown, Barbara Wenrich, Peter C. Adamson, Brigitte C. Widemann, Frank M. Balis
Izdano 2010Artigo -
9
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group od Elliot Stieglitz, Ashley F. Ward, Robert B. Gerbing, Todd A. Alonzo, R.J. Arceci, Y. Lucy Liu, Peter D. Emanuel, Brigitte C. Widemann, Jennifer W. Cheng, Nalini Jayaprakash, Frank M. Balis, Robert P. Castleberry, Nancy Bunin, Mignon L. Loh, Todd M. Cooper
Izdano 2014Artigo -
10
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Beva... od Brigitte C. Widemann, Yao Lu, Denise K. Reinke, Scott H. Okuno, Christian F. Meyer, Gregory M. Coté, Rashmi Chugh, Mohammed Milhem, Angela C. Hirbe, AeRang Kim, Brian Turpin, Joseph G. Pressey, Eva Dombi, Nalini Jayaprakash, Lee J. Helman, Ndidi Onwudiwe, Karen Cichowski, John P. Perentesis
Izdano 2019Artigo -
11
Sustained response and prevention of damage progression in patients with neonatal‐onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three‐ a... od Cailin H. Sibley, N. Plass, Joseph Snow, Edythe Wiggs, Carmen C. Brewer, Kelly King, Christopher Zalewski, H. Jeffrey Kim, Rachel Bishop, Suvimol Hill, Scott M. Paul, Patrick Kicker, Zachary N. Phillips, J. Gregory Dolan, Brigitte C. Widemann, Nalini Jayaprakash, Frank Pucino, Deborah L. Stone, Dawn Chapelle, Christopher S. Snyder, John A. Butman, Robert Wesley, Raphaela Goldbach‐Mansky
Izdano 2012Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Oncology
Refractory (planetary science)
Astrobiology
Gastroenterology
Physics
Toxicity
Pathology
Pharmacokinetics
Neurofibromatosis
Pharmacology
Adverse effect
Biology
Chemotherapy
Hepatocellular carcinoma
Methotrexate
Pediatrics
Phases of clinical research
Sorafenib
Anakinra
Antifolate
Antigen
Antimetabolite
Area under the curve
Bevacizumab
Biochemistry
C-reactive protein
CD19
Cancer